Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis
Table 4
Pathway statistics: G3_SGE+BEV_vs_SGE, fold change <0.25.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Pathway statistics: G3_SGE+BEV_vs_SGE, fold change <0.25.